Mazor holds related patents in other major markets throughout the world and has a solid IP position in global markets, including the US, Canada and Europe.
By Mark Ingebretsen
January 11, 2012
“This patent is an important new addition to our global intellectual property portfolio and increases the value of our spine franchise,” said Ori Hadomi, President & CEO of Mazor Robotics. “We believe this patent secures our unique surgical approach, as Mazor Robotics’ technology is the only system which is fixated to the patient’s anatomy, assuring the highest accuracy levels and reliability in spine surgeries, which would be almost impossible to emulate otherwise.”
This is a preview article. Please register to view the entire article.